TABLE 1.
Demographic and characteristics of COVID‐19 patient
Variables | Severe patients (n = 12) | Non‐severe patients (n = 98) | All patients (n = 110) | p‐Value |
---|---|---|---|---|
Age, median (min.–max.), years | 31 (21–36) | 30 (19–42) | 30 (19–42) | 0.758 a |
Gestational age, median (min.–max.), weeks | 35 (22–38) | 37 (28–41) | 37 (22–41) | 0.005 a |
Maternal country of birth | ||||
Turkey | 10 (83.3%) | 92 (93.9%) | 102 (92.7%) | 0.21 b |
Syria | 2 (16.7%) | 6 (5.1%) | 8 (7.3%) | |
Coexisting disorders | ||||
Pneumonia | 12 (100%) | 45 (45.6%) | 57 (51.8%) | 0.003 c |
Preeclampsia/hypertensive disease | 3 (25%) | 8 (8.2%) | 11 (10%) | 0.09 c |
Diabetes (pregestational and gestational) | 2 (16.7%) | 7 (7.1%) | 9 (8.1%) | 0.25 c |
Asthma | 2 (16.7%) | 3 (3.1%) | 5 (4.5%) | 0.091 c |
ASA score | ||||
2 | 3 (25%) | 79 (80.1%) | 82 (74.5%) | 0.001 c |
3 | 4 (33.3) | 16 (16.3%) | 20 (18.2%) | 0.22 c |
4 | 5 (41.7%) | 3 (3.1%) | 8 (7.3%) | <0.001 c |
Emergency operation | 8 (66.7%) | 18 (18.4) | 26 (23.6%) | <0.001 c |
Nulliparity | 1 (8.3%) | 17 (17.3%) | 18 (16.4%) | 0.68 c |
Twin pregnancies | 1 (8.3%) | 3 (3.1%) | 4 (3.6%) | 0.37 c |
Note: Significant values are in bold and italics.
Abbreviation: ASA, American Society of Anesthesiology.
Mann–Whitney U test.
Fisher exact test for two race groups.
Fisher exact test.